Carterra: IPA Acquires the Carterra LSA Instrument to Enhance Antibody Discovery and Bolster Its AI Developments

(marketscreener.com) Significant throughput of LSA to advance IPA's diversity- and data-driven drug development and to enrich LENSai .https://www.marketscreener.com/quote/stock/IMMUNOPRECISE-ANTIBODIES--40328863/news/IPA-Acquires-the-Carterra-LSA-Instrument-to-Enhance-Antibody-Discovery-and-Bolster-Its-AI-Developm-46240668/?utm_medium=RSS&utm_content=20240320